CellPort at Philly CGT 2026

Cell and gene therapy continues to advance, and conversations around CMC are evolving.

‍

At the 2026 Cell & Gene Therapy Annual Conference in Philadelphia, our CEO, Patrick Dentinger, will be presenting “CMC Isn’t the Problem — When You Start Is” on Friday, May 8, 2026, from 10:30 AM – 12:00 PM during the Session 1, CMC Track at the Sheraton Valley Forge Hotel in King of Prussia, PA.This talk will explore:

‍

• Why CMC itself isn’t the constraint—and how introducing structure too late can create gaps in process history, lineage, and context that are difficult to recover
• A practical approach to capturing work as it happens, supporting traceability, regulatory alignment, and consistent day-to-day execution
• How connected, contextualized data makes results easier to interpret over time—supporting reproducibility, comparability, and more confident decision-making

‍

With recent regulatory updates shaping how CMC is evaluated, the timing and structure of how work is captured is becoming increasingly important.